A novel method for measuring intestinal and hepatic triacylglycerol kinetics

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 8, 2013, Pages

  Sun, Feifei ^a   Stolinski, Mike ^a   Shojaee Moradie, Fariba ^a   Lou, Shaoying ^a   Ma, Yuying ^a   Hovorka, Roman ^b   Umpleby, A Margot ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Chylomicron; Immunoaffinity; Postprandial; Stable isotopes; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; CHYLOMICRON; ISOTOPE; LIPOPROTEIN; TRACER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTIBODY AFFINITY; ARTICLE; CATABOLISM; DIET RESTRICTION; ENZYME KINETICS; FEEDING; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METHODOLOGY; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; WESTERN BLOTTING;

CHYLOMICRON; IMMUNOAFFINITY; POSTPRANDIAL; STABLE ISOTOPES; VERY-LOW-DENSITY LIPOPROTEIN;

CARBON ISOTOPES; CHROMATOGRAPHY, AFFINITY; CHYLOMICRONS; DEUTERIUM; FASTING; FEMALE; HUMANS; INTESTINAL MUCOSA; INTESTINES; KINETICS; LIPOPROTEINS, VLDL; LIVER; MALE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84885618683     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00105.2013     Document Type: Article

References (37)

1. Ackermans MT, Ruiter AF, Endert E. Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography/mass spectrometry. Anal Biochem 258: 80-86, 1998.
2. Adiels M, Packard C, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Taskinen MR, Boren J. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J Lipid Res 46: 58-67, 2005.
3. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49: 755-765, 2006.
4. Assmann G, Schulte H, Funke H, von EA. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 19, Suppl M: M8-M14, 1998.
5. Backhouse K, Sarac I, Shojaee-Moradie F, Stolinski M, Robertson MD, Frost GS, Bell JD, Thomas EL, Wright J, Russell-Jones D, Umpleby AM. Fatty acid flux and oxidation are increased by rimonabant in obese women. Metabolism 61: 1220-1223, 2012.
6. Bjorkegren J, Packard CJ, Hamsten A, Bedford D, Caslake M, Foster L, Shepherd J, Stewart P, Karpe F. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron- like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 37: 76-86, 1996.
7. Cohly HH, Isokpehi R, Rajnarayanan RV. Compartmentalization of aquaporins in the human intestine. Int J Environ Res Public Health 5: 115-119, 2008.
8. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russell RM, Schaefer EJ. Contribution of apoB-48 and apoB-100 triglyceride- rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 34: 2033-2040, 1993.
9. Croset M, Rajas F, Zitoun C, Hurot JM, Montano S, Mithieux G. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 50: 740-746, 2001.
10. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, Sonksen PH. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38: 959-967, 1995.
11. Duez H, Lamarche B, Valero R, Pavlic M, Proctor S, Xiao C, Szeto L, Patterson BW, Lewis GF. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation 117: 2369-2376, 2008.
12. Farquhar JW, Gross RC, Wagner RM, Reaven GM. Validation of an incompletely coupled two-compartment nonrecyclying catenay model for turnover of liver and liver and plasma triglyceride in man. J Lipid Res 6: 119-134, 1965.
13. Fisher RM, Coppack SW, Humphreys SM, Gibbons GF, Frayn KN. Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clin Chim Acta 236: 7-17, 1995.
14. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
15. Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, Frayn KN. Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J Lipid Res 44: 2065-2072, 2003.
16. Hodson L, Bickerton AS, McQuaid SE, Roberts R, Karpe F, Frayn KN, Fielding BA. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes 56: 2433-2441, 2007.
17. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213-219, 1996.
18. Jensen MD, Ekberg K, Landau BR. Lipid metabolism during fasting. Am J Physiol Endocrinol Metab 281: E789-E793, 2001.
19. Karpe F, Humphreys SM, Samra JS, Summers LK, Frayn KN. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans. J Lipid Res 38: 2335-2343, 1997.
20. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 91: 748-758, 1993.
21. Kayden HJ, Senior JR, Mattson FH. The monoglyceride pathway of fat absorption in man. J Clin Invest 46: 1695-1703, 1967.
22. Krasinski SD, Cohn JS, Russell RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 39: 357-365, 1990.
23. Lehner R, Kuksis A. Biosynthesis of triacylglycerols. Prog Lipid Res 35: 169-201, 1996.
24. Lemieux S, Patterson BW, Carpentier A, Lewis GF, Steiner G. A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. J Lipid Res 40: 2111-2117, 1999.
25. Marcel YL, Hogue M, Weech PK, Davignon J, Milne RW. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function. Arteriosclerosis 8: 832-844, 1988.
26. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 77: 573-579, 2003.
27. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res 43: 223-233, 2002.
28. Pavlic M, Xiao C, Szeto L, Patterson BW, Lewis GF. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes 59: 580-587, 2010.
29. Pearson TC, Guthrie DL, Simpson J, Chinn S, Barosi G, Ferrant A, Lewis SM, Najean Y. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 89: 748-756, 1995.
30. Sarac I, Backhouse K, Shojaee-Moradie F, Stolinski M, Robertson MD, Bell JD, Thomas EL, Hovorka R, Wright J, Umpleby AM. Gender differences in VLDL1 and VLDL2 triglyceride kinetics and fatty acid kinetics in obese postmenopausal women and obese men. J Clin Endocrinol Metab 97: 2475-2481, 2012.
31. Saunders DR, Dawson AM. Studies on the metabolism of glycerol by the small intestine in vitro and in vivo. Biochem J 82: 477-483, 1962.
32. Uchida Y, Kurano Y, Ito S. Establishment of monoclonal antibody against human Apo B-48 and measurement of Apo B-48 in serum by ELISA method. J Clin Lab Anal 12: 289-292, 1998.
33. Wang X, Pease R, Bertinato J, Milne RW. Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism. Arterioscler Thromb Vasc Biol 20: 1301-1308, 2000.
34. Watts GF, Mandalia S, Brunt JN, Slavin BM, Coltart DJ, Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism 42: 1461-1467, 1993.
35. Williams CM. Postprandial lipid metabolism: effects of dietary fatty acids. Proc Nutr Soc 56: 679-692, 1997.
36. Zheng C, Ikewaki K, Walsh BW, Sacks FM. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J Lipid Res 47: 1771-1779, 2006.
37. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485, 1979.